About this trial
The PELICAN study is a prospective, non randomized, dual arm, multi-center clinical study comparing clinical outcomes of subjects treated with the LIFT Implant System to subjects treated with Tibial Tubercle Osteotomy (TTO).
Eligibility criteria
Qualifiers
Patients age 22 to 65 years at time of screening
Anterior knee pain due to patellofemoral cartilage degeneration (PCD) with an Modified Outerbridge score of ≥3 as assessed by an MRI on the study knee
Body Mass Index (BMI) of ≤ 35
Weight < 300 lbs
Disqualifiers
PCD with an Modified Outerbridge Score of 2 or less at the study knee
Clinical symptoms of the contralateral knee that preclude activities of daily living, stair climbing, stair descending, or require the use of an assist device
History of patella dislocation or instability
Patella alta or patella baja
Trial design
Treatments tested in this trial
- LIFT Implant
- Tibial Tubercle Osteotomy